YARAL Pharma focuses on innovative biopharmaceutical technologies aimed at addressing unmet medical needs. The company employs advanced drug delivery systems that enhance the efficacy and safety of therapeutic agents. Their proprietary platforms are designed to optimize the pharmacokinetics and pharmacodynamics of drugs, ensuring better patient outcomes. YARAL Pharma's commitment to research and development is evident in their pipeline, which includes a range of products targeting various therapeutic areas, including oncology and autoimmune diseases.

In addition to their drug delivery systems, YARAL Pharma emphasizes the importance of formulation science in their technology portfolio. They utilize cutting-edge techniques to develop stable and effective formulations that improve the bioavailability of active pharmaceutical ingredients. The integration of these technologies allows YARAL Pharma to create tailored solutions that meet the specific needs of patients and healthcare providers, ultimately contributing to the advancement of modern medicine.

United States

YARAL Pharma Inc. is the US subsidiary of IBSA, a global pharmaceutical company headquartered in Switzerland. By focusing on people and innovating the ways they're cared for, YARAL Pharma is proud to offer the same values and expertise of its parent company to the US market.

Dedicated to ensuring access to affordable authorized generics (AGs) and complex generic medicines that enhance healthcare outcomes, YARAL Pharma offers its customers high-quality products across a range of therapeutic areas, continuity of supply, and a commitment to exceptional customer service.

YARAL Pharma

Company Details